검색
Black Diamond Therapeutics Inc
BDTX관심 목록에 추가
2.580USD
-0.170-6.18%
종가 05/18, 16:00（ET）시세는 15분 지연됩니다
147.84M시가총액
손실P/E TTM
자세한 내용은 Black Diamond Therapeutics Inc 회사
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The Company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat central nervous system disease. The Company is advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. Its BDTX-4933 pipeline product is out-licensed to Servier. BDTX-4933 is designed to target RAS and RAF alterations in solid tumors. It is exploring partnership opportunities for its FGFR2/3 selective development candidate BDTX-4876.
Black Diamond Therapeutics Inc 정보
종목 코드 BDTX
회사 이름Black Diamond Therapeutics Inc
상장일Jan 30, 2020
CEOVelleca (Mark A)
직원 수24
유형Ordinary Share
회계 연도 종료Jan 30
주소245 First Street, 18Th Floor
도시CAMBRIDGE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02142
전화16174175868
웹사이트https://www.blackdiamondtherapeutics.com/
종목 코드 BDTX
상장일Jan 30, 2020
CEOVelleca (Mark A)
Black Diamond Therapeutics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Ali Behbahani, M.D.
Dr. Ali Behbahani, M.D.
Independent Director
Independent Director
93.57K
--
Ms. Erika Jones
Ms. Erika Jones
Senior Vice President - Finance, Principal Financial Officer and Principal Accounting Officer
Senior Vice President - Finance, Principal Financial Officer and Principal Accounting Officer
85.15K
--
Dr. Garry E. Menzel, Ph.D.
Dr. Garry E. Menzel, Ph.D.
Independent Director
Independent Director
76.64K
--
Dr. Prakash Raman, Ph.D.
Dr. Prakash Raman, Ph.D.
Independent Director
Independent Director
37.13K
--
Dr. Sergey Yurasov, M.D., Ph.D.
Dr. Sergey Yurasov, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
24.08K
--
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Independent Director
Independent Director
10.00K
--
Ms. Shannon Campbell
Ms. Shannon Campbell
Independent Director
Independent Director
8.87K
--
Dr. Elizabeth Buck, Ph.D.
Dr. Elizabeth Buck, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Brent M. Hatzis-Schoch, Esq.
Mr. Brent M. Hatzis-Schoch, Esq.
Chief Operating Officer, General Counsel
Chief Operating Officer, General Counsel
--
--
Dr. Samarth Kulkarni, Ph.D.
Dr. Samarth Kulkarni, Ph.D.
Lead Independent Director
Lead Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Ali Behbahani, M.D.
Dr. Ali Behbahani, M.D.
Independent Director
Independent Director
93.57K
--
Ms. Erika Jones
Ms. Erika Jones
Senior Vice President - Finance, Principal Financial Officer and Principal Accounting Officer
Senior Vice President - Finance, Principal Financial Officer and Principal Accounting Officer
85.15K
--
Dr. Garry E. Menzel, Ph.D.
Dr. Garry E. Menzel, Ph.D.
Independent Director
Independent Director
76.64K
--
Dr. Prakash Raman, Ph.D.
Dr. Prakash Raman, Ph.D.
Independent Director
Independent Director
37.13K
--
Dr. Sergey Yurasov, M.D., Ph.D.
Dr. Sergey Yurasov, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
24.08K
--
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Independent Director
Independent Director
10.00K
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Thu, May 14
마지막 업데이트: Thu, May 14
주주
주주 유형
주주
주주
비율
T. Rowe Price Investment Management, Inc.
18.51%
Versant Ventures
10.83%
New Enterprise Associates (NEA)
7.76%
Acadian Asset Management LLC
2.84%
Dimensional Fund Advisors, L.P.
2.27%
기타
57.78%
주주
주주
비율
T. Rowe Price Investment Management, Inc.
18.51%
Versant Ventures
10.83%
New Enterprise Associates (NEA)
7.76%
Acadian Asset Management LLC
2.84%
Dimensional Fund Advisors, L.P.
2.27%
기타
57.78%
주주 유형
주주
비율
Investment Advisor
28.81%
Venture Capital
18.80%
Investment Advisor/Hedge Fund
17.54%
Hedge Fund
6.36%
Research Firm
2.62%
Individual Investor
1.07%
Pension Fund
0.60%
Family Office
0.02%
기타
24.18%
기관 주식 보유
마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
265
45.02M
78.72%
-14.97M
2025Q4
251
45.27M
104.04%
+4.70K
2025Q3
261
45.26M
106.75%
+270.69K
2025Q2
263
45.72M
119.11%
-2.33M
2025Q1
244
48.05M
134.35%
-28.07M
2024Q4
236
55.25M
127.86%
-855.91K
2024Q3
237
56.09M
121.86%
+1.99M
2024Q2
230
54.06M
101.77%
+8.09M
2024Q1
233
46.69M
117.14%
-13.89M
2023Q4
222
46.16M
104.70%
+1.30M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
T. Rowe Price Investment Management, Inc.
10.61M
18.51%
-137.51K
-1.28%
Dec 31, 2025
Versant Ventures
6.21M
10.83%
-221.60K
-3.45%
Apr 11, 2025
New Enterprise Associates (NEA)
4.45M
7.77%
--
--
Dec 31, 2025
Acadian Asset Management LLC
1.63M
2.85%
+1.15M
+238.83%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
857.01K
1.5%
+401.14K
+88.00%
Dec 31, 2025
Marshall Wace LLP
1.11M
1.94%
-189.12K
-14.56%
Dec 31, 2025
Connor, Clark & Lunn Investment Management Ltd.
654.70K
1.14%
+523.06K
+397.36%
Dec 31, 2025
Invus Public Equities Advisors, LLC
1.05M
1.83%
--
--
Dec 31, 2025
Arrowstreet Capital, Limited Partnership
1.04M
1.82%
+143.62K
+16.01%
Dec 31, 2025
Renaissance Technologies LLC
949.74K
1.66%
+350.33K
+58.45%
Dec 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Fidelity Enhanced Small Cap ETF
0.05%
iShares Micro-Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
DFA Dimensional US Small Cap Value ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Health Innovation Active ETF
0%
Vanguard US Momentum Factor ETF
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
더 보기
Fidelity Enhanced Small Cap ETF
비율0.05%
iShares Micro-Cap ETF
비율0.03%
Avantis US Small Cap Equity ETF
비율0.02%
Invesco RAFI US 1500 Small-Mid ETF
비율0.01%
DFA Dimensional US Small Cap Value ETF
비율0%
iShares Russell 2000 Value ETF
비율0%
iShares Health Innovation Active ETF
비율0%
Vanguard US Momentum Factor ETF
비율0%
ProShares Hedge Replication ETF
비율0%
iShares Russell 2000 Growth ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
